Annual Cash & Cash Equivalents
$239.09 M
+$22.63 M+10.46%
December 1, 2024
Summary
- As of March 13, 2025, VCYT annual cash & cash equivalents is $239.09 million, with the most recent change of +$22.63 million (+10.46%) on December 1, 2024.
- During the last 3 years, VCYT annual cash & cash equivalents has risen by +$65.89 million (+38.04%).
- VCYT annual cash & cash equivalents is now -31.57% below its all-time high of $349.36 million, reached on December 31, 2020.
Performance
VCYT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$239.09 M
-$34.99 M-12.77%
December 31, 2024
Summary
- As of March 13, 2025, VCYT quarterly cash and cash equivalents is $239.09 million, with the most recent change of -$34.99 million (-12.77%) on December 31, 2024.
- Over the past year, VCYT quarterly cash and cash equivalents has stayed the same.
- VCYT quarterly cash and cash equivalents is now -31.57% below its all-time high of $349.36 million, reached on December 31, 2020.
Performance
VCYT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VCYT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.5% | 0.0% |
| 3 y3 years | +38.0% | +38.0% |
| 5 y5 years | +50.1% | +50.1% |
VCYT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +55.0% | -12.8% | +55.8% |
| 5 y | 5-year | -31.6% | +55.0% | -31.6% | +62.1% |
| alltime | all time | -31.6% | +3060.0% | -31.6% | +1607.5% |
Veracyte Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $239.09 M(-12.8%) |
| Dec 2024 | $239.09 M(+10.5%) | - |
| Sep 2024 | - | $274.08 M(+16.2%) |
| Jun 2024 | - | $235.91 M(+12.8%) |
| Mar 2024 | - | $209.19 M(-3.4%) |
| Dec 2023 | $216.45 M(+40.3%) | $216.45 M(+6.9%) |
| Sep 2023 | - | $202.46 M(+5.9%) |
| Jun 2023 | - | $191.14 M(+7.4%) |
| Mar 2023 | - | $177.89 M(+15.3%) |
| Dec 2022 | $154.25 M(-10.9%) | $154.25 M(-9.3%) |
| Sep 2022 | - | $170.11 M(+10.9%) |
| Jun 2022 | - | $153.45 M(-6.2%) |
| Mar 2022 | - | $163.62 M(-5.5%) |
| Dec 2021 | $173.20 M(-50.4%) | $173.20 M(+5.6%) |
| Sep 2021 | - | $164.03 M(-49.9%) |
| Jun 2021 | - | $327.55 M(+1.1%) |
| Mar 2021 | - | $324.06 M(-7.2%) |
| Dec 2020 | $349.36 M(+119.3%) | $349.36 M(+1.2%) |
| Sep 2020 | - | $345.08 M(+134.0%) |
| Jun 2020 | - | $147.45 M(-3.7%) |
| Mar 2020 | - | $153.13 M(-3.9%) |
| Dec 2019 | $159.32 M(+104.3%) | $159.32 M(-18.6%) |
| Sep 2019 | - | $195.66 M(+1.6%) |
| Jun 2019 | - | $192.65 M(+184.0%) |
| Mar 2019 | - | $67.84 M(-13.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $78.00 M(+130.1%) | $78.00 M(+0.2%) |
| Sep 2018 | - | $77.85 M(+227.7%) |
| Jun 2018 | - | $23.76 M(-12.5%) |
| Mar 2018 | - | $27.15 M(-19.9%) |
| Dec 2017 | $33.89 M(-42.8%) | $33.89 M(-17.7%) |
| Sep 2017 | - | $41.20 M(-11.3%) |
| Jun 2017 | - | $46.46 M(-9.8%) |
| Mar 2017 | - | $51.51 M(-13.0%) |
| Dec 2016 | $59.22 M(+51.5%) | $59.22 M(+86.8%) |
| Sep 2016 | - | $31.70 M(-18.7%) |
| Jun 2016 | - | $38.99 M(-17.8%) |
| Mar 2016 | - | $47.46 M(+21.4%) |
| Dec 2015 | $39.08 M(+11.6%) | $39.08 M(-15.2%) |
| Sep 2015 | - | $46.12 M(-9.7%) |
| Jun 2015 | - | $51.05 M(+97.9%) |
| Mar 2015 | - | $25.80 M(-26.3%) |
| Dec 2014 | $35.01 M(-50.8%) | $35.01 M(-20.4%) |
| Sep 2014 | - | $44.00 M(-24.1%) |
| Jun 2014 | - | $58.00 M(-9.7%) |
| Mar 2014 | - | $64.24 M(-9.8%) |
| Dec 2013 | $71.22 M(+408.6%) | $71.22 M(+361.7%) |
| Sep 2013 | - | $15.43 M(-25.4%) |
| Jun 2013 | - | $20.68 M(+47.7%) |
| Dec 2012 | $14.00 M(+85.1%) | $14.00 M |
| Dec 2011 | $7.57 M | - |
FAQ
- What is Veracyte annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Veracyte?
- What is Veracyte annual cash & cash equivalents year-on-year change?
- What is Veracyte quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Veracyte?
- What is Veracyte quarterly cash and cash equivalents year-on-year change?
What is Veracyte annual cash & cash equivalents?
The current annual cash & cash equivalents of VCYT is $239.09 M
What is the all time high annual cash & cash equivalents for Veracyte?
Veracyte all-time high annual cash & cash equivalents is $349.36 M
What is Veracyte annual cash & cash equivalents year-on-year change?
Over the past year, VCYT annual cash & cash equivalents has changed by +$22.63 M (+10.46%)
What is Veracyte quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VCYT is $239.09 M
What is the all time high quarterly cash and cash equivalents for Veracyte?
Veracyte all-time high quarterly cash and cash equivalents is $349.36 M
What is Veracyte quarterly cash and cash equivalents year-on-year change?
Over the past year, VCYT quarterly cash and cash equivalents has changed by $0.00 (0.00%)